| Tag | Content |
|---|
EnhancerAtlas ID | HS134-01165 |
Organism | Homo sapiens |
Tissue/cell | Mesendoderm |
Coordinate | chr1:44901660-44903720 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| GATA2 | MA0036.3 | chr1:44903127-44903138 | TTCTTATCTTC | + | 6.02 | | HNF1A | MA0046.2 | chr1:44902964-44902979 | TATTAATGATTAGCT | + | 6.21 | | HNF1B | MA0153.2 | chr1:44902965-44902978 | ATTAATGATTAGC | - | 6.18 | | STAT3 | MA0144.2 | chr1:44903666-44903677 | CTTCTGGGAAA | + | 6.62 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_13429 | chr1:44901466-44902619 | CD34_Primary_RO01536 | | SE_13429 | chr1:44903037-44904563 | CD34_Primary_RO01536 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr1 | 44903207 | 44903387 | | chr1 | 44902158 | 44902600 |
|
| | Number: 2 | ID | Chromosome | Start | End |
| GH01I044435 | chr1 | 44901467 | 44902619 | | GH01I044437 | chr1 | 44903038 | 44904563 |
|
Enhancer Sequence | TCTCTCAGCT CAGTTCTTCC CTCTGATTTT AGGAGGAGTC AAATCCCTCT CCTTCCATTT 60
CCAAGTTTAA CAGAATCGTC CTAATGTATA TGCCTCCTTG ACACACAAAG TCCCTGAAGC 120
AAGTTTCCAC TTTTCTCTGC AAAAGCTCCC TGGAGCGCAG GGAGCTCTTG TCTTGTATCT 180
AGTTAAATGC CTCGATTAAG GATGTAATCA TAGTTGTTTG GCTCTGTAAA TCATTTGACC 240
CTCACCTAAA GCAGCCTGGG CCTCTGGGGG GCCCAGCAAT GACCATTCTG AATCTGGGAG 300
GACAGAGTGG AGCTGGAGAT GGCTTTCACC CTTAGTGGAA AGACAGCCAG TTTTAGGGGG 360
GGTAATATAT TTTTCTTTTT CCCTAGGTTT TCTTGTCGAG ATCGTGTGTG TGCTCACACA 420
CACACATGTG TGAGCAAAAG AGAGAATAAA AAGAAAGAGG AAAAGGCCCA ACAGTGTACA 480
GCAACTGCTA GCACAAAGGC CAGGGGAGGG ACTTGCAGAG AAAGACAAGG AAGTGATTTT 540
GCCCAGTTTA AATCCCACTT GAACCATGTG GTTTCTGAGT CCTGAACCTT TTGAGGTTCA 600
AGTTGAGTGC ACTCTTGACA AAACATGATT TTCTGGTTCA CATCAAAAAG GCTTTAAAAG 660
ACTTCGAAGT CTTTTCCTTA GGACATCAAA CAGTCCACAA CAAAGCAGGG TGCTGATGAG 720
ATGCGTGCAA ATGAACAGAT TAAATTCTCT CCTGAGGATT AGATTCTCCT TAAGAAGCAT 780
GTGAAGTTGG AAACTTGGGA GATGGGGCAA TGCCAAAACA TACTCACACT CTTGGGACCC 840
CAGAGCGCCC TCTCGTCTGT TTACCCCTGG CACCTCCCTG GGCCTGGAAG CTGACCTTAT 900
TTGTTATGAA GTTCACACAG AAGTGCCCAG GGAATTAGAA ACTGAAAACA AACTCTTCAG 960
GATTCTCTAT CTTGCCTAAG GCAACACTTA TGTCCCCCAG TAAAAGGTGT AAATTAACTT 1020
AGAAAAGATA GGTCATTCCT TTGAAAAACT GACAGTTGTT TGGGTGGCTT AGAGCACAAT 1080
TTTGCTTATT GAACGAGCCT CAATCTTCAG AGAAGTAAGT ATTTAGAAGA CTACTACTGC 1140
CTTATGGCAA ATGGAATAGC ACGCTTTGGG AGTGGCATAG CAAACCAACC AATGCGGTAG 1200
ACTTTCTGTT TCCAAGTGAG CAGCTAAAGC TAAAGTCGAT TGCATAGACA CAGCTGTGGG 1260
TGGGCCAACT GCATGAGCAC AGTTTCTGAG CCAAGCCGCT AAAATATTAA TGATTAGCTT 1320
TAAGGAGGAG CAATTCTGAT TGAGGCCACT CTCCTGTTAG AAACCATAAT TAGCAATTAA 1380
AATATATTCT AAAAACTGTT CCAACCAGCA GCTTTTAAAT AAATAATTGT CACTGCTGAT 1440
TGAACTTGTT TTATTTCCCT GTGATTTTTC TTATCTTCCC CCACCCCACC CCGCATAACT 1500
TACAACCCTG TAAATGCTCA GTAGCTGTTA ATATGAGTCT GTCAATACAT TTACCATGGT 1560
GACTTGGGCT GTATTTGGCG AGCATTTGAA GAAATCAGTC ACTGGTTGGA GGGAGGAAAG 1620
ACAAGCTGTC GATATCCAGG GAGAAATGCT AATAACCCTG GTGACAAATC GTCCTCTGGA 1680
TTCTCTAAGG GTTAAGAAAA AGCACCTCTT AGACCTGGGA GCTCAGGGGT AAGGGATGGT 1740
GACTTGTTAG GAAGTGCAGA CAGTAGCTGT CATGATCTGC AATGTCCTTT TCATTGTCTT 1800
GCTTTCAACC TCTCAAAACC ACAGATGAGT TCTGGAGACA GACAGGCCTG GATTTGAATC 1860
CTGATTCAAT CCACTGTGTA ACTGTGTGAT CTTGCAACCA CTGAACCTTC ATTTTCTCAT 1920
CTGTAAATTA AAGATTGTAA TACCTGGCCT CATGAGGGGT TGGGAAAGGC CTTAAACAGA 1980
GACACTAACT TACTGTTTCT CAAACTCTTC TGGGAAAATA CACATATAGA AGAAAACTAA 2040
CTTCTGCCCT CCAGCATTGC 2060
|
